
Drug Discovery
Targeting undruggable RAS proteins in cancer
It is estimated that one in five human cancers involve RAS mutations. Although once considered undruggable, this blog looks at recent advances in RAS inhibitors and emerging therapies.
Zach Baum is an information scientist at CAS. He earned his Ph.D. in Inorganic Chemistry in 2018 from The Ohio State University, where he studied organometallic chemistry and the electronic structures of low-dimensional materials.